Science and Technology: Considerations for Maintaining U.S. Competitiveness in Quantum Computing, Synthetic Biology, and Other Potentially Transformational Research Areas

Scientific and technological innovation contributes to U.S. economic competitiveness and prosperity. Federal agencies support transformational technological advances—those that result in new or significantly enhanced technologies—by, for example, funding research (nearly $70 billion in obligations in fiscal year 2017).

GAO was asked to examine support for research that could lead to transformational technological advances. This report (1) describes federal agencies' and nonfederal entities' support for such research in selected areas, (2) examines federal agencies' coordination on this research, and (3) describes experts' views on considerations for maintaining U.S. competitiveness through such advances. GAO selected quantum computing and synthetic biology as examples of research areas that could lead to transformational technological advances. GAO reviewed agency documents and interviewed federal officials, subject matter experts, and stakeholders. GAO also worked with the National Academies of Sciences, Engineering, and Medicine to convene a meeting to solicit views from 19 experts selected from government, academia, and industry, among others.

Multiple federal and nonfederal entities support research for transformational technological advances in the areas of quantum computing—the manipulation of bits of data using the behavior of individual atoms, molecules, or other quantum systems to potentially outperform supercomputers—and synthetic biology—the combination of biology and engineering to create or modify biological systems. GAO found that at least 6 agencies support quantum computing research; at least 10 agencies support synthetic biology research; and nonfederal entities, such as universities and businesses, support research in both areas.

Agency officials said they coordinate on quantum computing and synthetic biology through efforts such as conferences and interagency groups, but GAO found that certain new efforts have not fully implemented selected leading collaboration practices. The quantum computing group, co-chaired by officials from 4 agencies, and the synthetic biology group, led by the National Science Foundation, have taken initial steps to implement some leading practices GAO identified that can enhance and sustain interagency collaboration. For example, both groups agreed to coordinate their research, and participating agencies documented agreement with the quantum computing group's purpose through a charter. However, the groups have not fully implemented other practices, such as agreeing on roles and responsibilities and identifying common outcomes, that could help ensure they effectively marshal agencies' efforts to maintain U.S. competitiveness in quantum computing and synthetic biology.

Experts identified considerations for maintaining U.S. competitiveness through transformational technological advances. The considerations broadly address federal and nonfederal entities' roles in supporting such advances and include:

developing a strategic approach using consortia or other mechanisms to bring together potential partners;

fostering an environment in which information is shared among researchers while also considering the risks of information sharing;

focusing on technology development and commercialization, for example, by providing support across multiple stages of technology innovation; and

strengthening the science and technology workforce through training, recruiting, and retaining talent.

GAO recommends that the agencies leading the interagency quantum computing and synthetic biology groups take steps to fully implement leading collaboration practices. The agencies agreed with GAO's recommendations.

Federal support for research and development can accelerate innovation,  drive technological advances, and promote U.S. competitiveness in the  global economy. For example, federally supported research led to the  introduction of global positioning systems and touchscreen technologies  that contributed to the development of smartphones, creating new  industries and significant economic growth. In fiscal year 2017, the  federal government obligated nearly $70 billion for research, according to  the National Science Foundation (NSF). While some research leads to  incremental changes in a scientific field, other research can yield  disruptive or transformational advances. These advances are  transformational because they result in new technologies or significantly  enhanced capabilities in existing technologies.

The United States is considered a world leader in many science and  technology areas, but other countries, such as China, are also making  considerable investments in research. Increased competition from these  countries has led some experts and others to express concern that the  United States may be losing its competitive advantage. In January 2018,  NSF’s National Science Board reported that the United States’ overall  global share of research and development spending is declining relative  to other countries. Moreover, other reports indicate that the United  States is losing ground in certain technologies, such as intense ultrafast  lasers, which may have applications in manufacturing, medicine, and  national security.

Since 2007, a series of laws has built on prior federal efforts to invest in  innovation through research and development and to improve the United  States’ competitiveness. In 2007, the America Creating Opportunities to  Meaningfully Promote Excellence in Technology, Education, and Science  Act (COMPETES 2007) established the Advanced Research Projects  Agency-Energy (ARPA-E) in the Department of Energy (DOE) to  overcome long-term and high-risk technological barriers in the  development of energy technologies. It also, among other things,  authorized programs in the Department of Education and NSF to train  teachers in science, technology, engineering and math (STEM) fields. In  2011, the COMPETES Reauthorization Act of 2010 reauthorized parts of  COMPETES 2007, established several new programs, and authorized  additional funding for STEM education. In 2017, the American Innovation  and Competitiveness Act of 2017 reauthorized some parts of the  COMPETES acts. The three acts also provided direction to the Office of Science and Technology Policy (OSTP), whose responsibilities include  coordinating federal research programs, advising the President on  scientific and technological considerations with regard to federal budgets,  and advising the President of scientific and technological considerations  involved in areas of national concern.

However, continued concerns related to the federal debt and federal  budget deficits are forcing difficult decisions about how much the federal  government should spend on research, as well as what types of research  it should fund. These concerns overlie a long-standing debate about the  federal government’s role in supporting science and technology research  and which roles should be left to the private sector, academia, or other  nonfederal entities. We have reported that the government often funds  research at the early stages of technology development, whereas industry  typically supports the final stages of technology development. As a  result, U.S. innovators may find it difficult to obtain public funding or  private investment during the middle stages of innovation. We have also  reported that substantial amounts of funding or investment are needed to  support technology maturation through the middle stages of innovation  and that high costs can be a barrier to technology commercialization,  especially for small and medium-sized U.S. enterprises. Long-standing  disagreements among stakeholders about the appropriateness of the  federal government taking an active role in supporting technological  advances with ambiguous applications has led to the creation, and  sometimes the dissolution, of programs such as the Advanced  Technology Program and the Technology Innovation Program. These two  programs were established to help U.S. businesses and organizations  support, promote, and accelerate innovation through high-risk, high- reward research in areas of critical national need. Different perspectives  on the appropriate federal role may have also led to the proposals in the  President’s Budget for fiscal years 2018 and 2019 to eliminate ARPA-E.

You asked us to examine federal and nonfederal support for research that  could accelerate innovation and advance U.S. competitiveness. This  report (1) describes federal agencies’ and nonfederal entities’ support for  research for transformational technological advances in selected areas,  (2) examines federal agencies’ coordination on this research, and (3)  provides experts’ views on considerations for maintaining U.S.  competitiveness through transformational technological advances.

To address these objectives, we selected quantum computing (a sub- area of quantum information science) and synthetic biology as examples  of areas of research that could lead to transformational technological  advances. We selected these two areas based on several factors,  including that they (1) represent enabling or platform technologies, (2) are  supported by a mix of federal agencies and nonfederal entities, and (3)  represent areas of congressional interest in which we have not recently  conducted work. For the purposes of our report, we defined quantum  computing as computing in which bits of data are manipulated by using  the behavior of atoms, molecules, or other quantum systems, with the  potential to carry out extremely complicated calculations for specific  problems that can outperform conventional supercomputers. We defined  synthetic biology as the intersection of biology and engineering that  focuses on the modification or creation of novel biological systems for  useful purposes.

To describe federal agencies’ and nonfederal entities’ support for  research that could lead to transformational technological advances in  quantum computing or synthetic biology, we focused on federal and  nonfederal efforts in fiscal year 2016 through the second quarter of fiscal  year 2018. We reviewed agency documentation, relevant literature, and  our prior work related to federal research efforts. We also interviewed  officials from federal agencies that support quantum computing or  synthetic biology research, as well as subject matter experts in the areas  of quantum computing, synthetic biology, or federal research more  broadly from industry, academia, nonprofit organizations, and  professional associations. We included 10 agencies in our review:  Department of Commerce, Department of Defense (DOD), Environmental  Protection Agency (EPA), DOE, Department of Homeland Security  (DHS), Department of Health and Human Services (HHS), National  Aeronautics and Space Administration (NASA), NSF, Office of the  Director of National Intelligence (ODNI), and the U.S. Department of  Agriculture (USDA). We did not seek to develop comprehensive  information on federal agencies’ and nonfederal entities’ efforts to support  research in quantum computing and synthetic biology. As a result, federal  agencies and nonfederal entities could have efforts in these two areas  that we do not discuss in our report.

To examine federal agencies’ coordination on quantum computing and  synthetic biology research, we identified coordination efforts that took  place in fiscal year 2016 through the second quarter of fiscal year 2018  during our review of agency documentation and interviews with federal  officials, including OSTP officials. We then compared these efforts with  selected leading practices for enhancing and sustaining collaboration.  We selected six of the eight leading practices based on their relevance to  the operations of the interagency coordination efforts we identified. In  this report, and in our past work, we define collaboration as any joint  activity that is intended to produce more public value than could be  produced when organizations act alone.

To provide experts’ views on considerations for maintaining U.S.  competitiveness through transformational technological advances, we  convened a meeting of 19 experts in October 2017, with the assistance of  the National Academies of Sciences, Engineering, and Medicine. The  experts included current and former federal officials and subject matter  experts from industry, academia, nonprofit organizations, and  professional associations. About half of the experts were subject matter  experts in quantum computing or synthetic biology, while the other half  were experts with broader perspectives on the role of federal and  nonfederal entities in supporting research for transformational  technological advances. We worked with the National Academies to  select experts with a range of viewpoints. We used a transcript of the  meeting in analyzing information obtained from these experts. See  appendix I for more detailed information on the scope and methods of our  review and appendix II for a list of the experts who participated in the  meeting we convened.

We conducted this performance audit from November 2016 to September  2018 in accordance with generally accepted government auditing  standards. Those standards require that we plan and perform the audit to  obtain sufficient, appropriate evidence to provide a reasonable basis for  our findings and conclusions based on our audit objectives. We believe  that the evidence obtained provides a reasonable basis for our findings  and conclusions based on our audit objectives.

This section provides information on translating research into new  products or services, the federal government’s role in supporting  research, and OSTP’s role in fostering collaboration among the various  entities. It also provides information on the areas of quantum computing  and synthetic biology.

Translating Research into New Products or Services

Technological innovation involves not only creating new ideas but also  translating those ideas into a new product or service. Innovation, and  the research driving it, is inherently risky because the likelihood that  research can be translated into a product or service and the ultimate  value of that product or service are unknown. Because of this risk and the  long time frames sometimes associated with technology development,  there can be a gap in funding and investment support that makes it  challenging to translate research into commercialized products or  services. While government and universities often support early-stage  research and industry tends to support later stages of development, there  may be a gap during the middle stages of innovation during which  innovators may have difficulty finding financial support, as illustrated in  figure 1 (see app. III for a printable version).

The linear, or pipeline, model of innovation presents innovation as a  succession of outputs that transfer to the next level as inputs. The starting  point in the pipeline model is basic research. Knowledge created through  basic research transitions to the next stage of applied research then to  development and, finally, commercialization. Under this model, innovation  takes place in distinct and sequential phases.

Critics of the pipeline model have noted that innovation is actually cyclical  because the development of knowledge involves feedback and interaction  at these different stages of the cycle. Alternative innovation models  include the following:

Extended pipeline model. Under this model certain research and development organizations support the entire technology development process, from basic research to initial commercialization. Unlike the pipeline model, in which the government’s support is disconnected from the rest of the innovation ecosystem, under the extended pipeline model the government’s role is deeply connected to the rest of the system. Under this model, federal entities such as DOD support the evolution of technologies, including electronics, computing, and the internet, across all stages of innovation.

Induced innovation model. Innovation that follows this model is more industry-led because the parties involved have a market niche that the research needs to meet. Research under this model is more likely to lead to incremental advances because it is conducted in response to market demand.

Manufacturing-led model. Under this model, innovation is pursued with the main objective of manufacturing. This model describes innovations in production technologies, processes, and products that emerge from the manufacturing process. The production process is supplemented by applied research and development. It is typically industry-led but may have strong government support, particularly in countries such as Germany, Japan and China whose economies are organized around this model.

While the different innovation models receive various levels of federal  support, examining the organization of federal agencies in support of  innovation is complex because of the decentralized nature of the federal  research system. More than 25 federal agencies support intramural or  extramural research, and these agencies may play different roles in  supporting research that may lead to potentially transformational  technologies. For example, NSF supports basic research that is in  keeping with its mission of promoting the progress of science; advancing  the national health, prosperity, and welfare; and securing the national  defense. DOD supports research in line with its mission to provide the  military forces needed to deter war and to protect the United States’  security, while DOE supports research in line with its mission to ensure  America’s security and prosperity by addressing its energy,  environmental, and nuclear challenges. Commerce’s National Institute of  Standards and Technology (NIST) supports research in measurement  science, standards, and technology, in keeping with its mission to  promote innovation and industrial competitiveness. Other agencies—such  as EPA, and HHS’s Food and Drug Administration—support research in  their capacity as regulatory agencies.

Federal support for research is not only decentralized but also changes  over time. Factors such as international conflict, budgetary pressures,  and globalization may contribute to shifts in U.S. science and technology  policy. In times of war, federal support for research has increased in  part because of the view that America’s military survival might depend on  science and technology leadership. Budgetary pressures also affect the  federal role in research when such pressures lead to reductions in federal  funding for research. Globalization and the associated integration of the  world economy may also affect federal science and technology policy.  While the United States invests far more resources in research and  development than any other country, its rank in research and  development intensity has slowly fallen in recent years.

Researchers have said that, in addition to globalization, domestic  changes—such as the structure of U.S. companies—present new  challenges to commercializing new products and services. For example,  in the last few decades, the amount of research produced by industrial  laboratories has declined. Further, U.S. companies, particularly small and  midsized firms, devote fewer resources to train employees compared to  firms from the 1980s. In recognition of the need for a more skilled  workforce to enhance U.S. competitiveness, the federal government has  increasingly shifted attention to preparing students for careers in STEM  fields.

The federal role also changes in response to differing policy views. One  policy perspective maintains that the federal role should be to support  innovation across the economy. This policy approach has underpinned  innovation and economic growth since at least the end of World War II.  As we reported previously, another perspective is that the federal role  should be to support individual sectors. Critics of the latter perspective  argue that the government should not “pick winners and losers” in  commercial contexts because it is unlikely that the government will have  sufficient information or foresight about an individual firm’s or a particular  technology’s growth potential to select it for special subsidy. This view  advocates allocating resources through market mechanisms because  such mechanisms are anticipated to result in U.S. investments that are  most efficient and best suited to the comparative advantages of the  United States. However, the federal government has supported  individual sectors from research and development through  implementation, most often because of the government’s own needs in  areas deemed important for national security (e.g., aerospace and  defense). In addition, findings of economic market failures have justified  other interventions, such as for research, development, and  demonstrations in various sectors, including agriculture and energy, and  recently, advanced production technologies.

The federal government has partnered with nonfederal entities to  translate research into commercialized products to foster economic  growth. For example, DOD, through programs such as the Defense  Advanced Research Projects Agency (DARPA), has partnered with  nonfederal entities to support both early-stage research and later-stage  production. Some of these partnerships have led to development of  transformational technologies. For example, in the 1970s DOD supported  development of a communications network to facilitate information  sharing, which is considered the foundation of the modern internet.

DOD also funded research in the 1950s on speech recognition and  artificial intelligence that commercial companies leveraged in the 1990s  and 2000s to develop technologies such as the Speech Interpretation and  Recognition Interface, the iPhone assistant. NIST research, such as its  critical technical evaluations of speech recognition technologies dating  back to the 1980s, also contributed to the development of Speech  Interpretation and Recognition Interface, according to NIST officials.  Alongside DOE, HHS and NSF, DOD has funded research that led to  technologies used to make the first iPod and later the iPhone (see fig.  2). Many federal agencies also support other mechanisms, such as  Small Business Innovation Research and Small Business Technology  Transfer grants, to stimulate innovation by facilitating interactions among  the federal government, private sector, and nonprofit research institutions.

OSTP was established in 1976 to provide advice on the scientific,  engineering, and technological aspects of issues that require attention at  the highest levels of government. Advances in technology in areas such  as quantum computing and synthetic biology have become increasingly  interdisciplinary, and OSTP works with agencies across the decentralized  federal research system to coordinate activities to support these  advances. The National Science and Technology Council (NSTC) is a key  component of these efforts and is charged with coordinating science and  technology policy across the federal government. One of the NSTC’s  primary objectives is to establish clear national goals for federal science  and technology investments. NSTC organizes its work under six  committees, such as the Committee on STEM Education, which is  responsible for coordinating federal programs and activities in support of  STEM education. In addition to pulling together federal entities, OSTP  also plays a role in pulling together nonfederal entities to help tackle  technological issues of importance to the nation. For example, the  National Strategic Computing Initiative, created in 2015, is a government  collaboration with industry and academia to sustain and enhance U.S.  leadership in high-performance computing.

Quantum computing has the potential to revolutionize computing by  introducing a fundamentally new approach to computing not available  with classical computers, which constitute most computers in use today.  Classical computers process two different states as 1s and 0s (binary  digits) to form “bits” of information that the computer manipulates. Bits  can exist in either a 1 or 0 state. These bits may be created using, for  example, specific voltage or current levels in a circuit, and there is a limit  as to how quickly transistors in classical computers can manipulate these  bits to conduct calculations or how many circuit components can be  included on a computer chip. While classical computers rely on bits,  quantum computers rely on quantum bits (“qubits”). Unlike bits, qubits  can be in combinations of both a 1 and a 0 at the same time due to  quantum superposition. Phenomena such as quantum superposition and  quantum entanglement (the ability of two particles to have correlated  information, even at a distance) make quantum computers more powerful  than even today’s most advanced classical supercomputers for solving  some complex problems. This ability to exist in combinations of both  states simultaneously allows for the efficient implementation of certain  algorithms, resulting in the ability to solve certain types of problems  significantly faster than classical computers.

To date, a universal quantum computer is not commercially available.  As of 2017, quantum computers contain at most 50 qubits and can  perform some small calculations more slowly than classical computers.  Among the challenges to building a quantum computer are developing  software and hardware. Quantum hardware allows the computer to  manipulate qubits by completely isolating quantum processors from  outside forces. Quantum computing hardware is at the laboratory  prototype stage and is progressing steadily, according to a 2016 federal  report. Hardware development efforts include the creation of logical  qubits, which use error correction techniques to actively mitigate errors,  thus stabilizing the quantum state of the qubit even in the presence of  external factors (i.e., noise). Quantum information is extremely fragile and  requires special techniques and equipment, such as extreme  refrigeration, to maintain the qubit. Other challenges include creating  qubits of high quality, packaging them together in a scalable form so they  can perform complex calculations in a controllable way, and limiting the  errors that can result from heat and electromagnetic radiation. Addressing  these challenges may require developing new materials. Stakeholders  still consider developing a universal quantum computer a long-term goal.  When available, these computers could provide new computational  methods and powerful new tools for researchers. Quantum computing  has the potential to support significant breakthroughs in medicine,  manufacturing, artificial intelligence, defense, and improved  cybersecurity. However, it may take a decade or more before such  technology is ready to be demonstrated at scale.

Synthetic biology represents an intersection of biology and engineering  that focuses on the modification or creation of novel biological systems.  The current state of synthetic biology is mostly the result of research in  biology, engineering, computer science, and information technology  dating back to the mid-1900s. Synthetic biology has drawn increasing  attention as a potentially transformative platform technology. Whether  found in nature or synthesized in a test tube, the building blocks of  synthetic biology are assembled to create biological systems. Synthetic  biological systems can function in cell-free environments, such as cell  extracts, or may be placed into living cells, such as bacteria, which serve  as a “chassis.” In the short-term, synthetic biology is enhancing  understanding of how living organisms work through progress in the  ability to design and construct biological parts.

Synthetic biology is already being applied in a variety of fields. Through  the creation of novel biological systems, synthetic biology offers potential  solutions to many current challenges, such as climate change, energy  needs, and global health. For example, synthetic biology may help  address global warming through the development of artificial leaf  technology, a synthetic version of the photosynthesis process. In the  energy sector, synthetic biology is being used to devise more efficient  methods of producing biofuels, and in the healthcare sector, synthetic  biology may lead to biosensors that can permanently reside in the body to  detect and treat abnormalities such as cancer. Synthetic biology has  already resulted in biosensors that can detect arsenic in drinking water.  Factors that may support growth in synthetic biology applications include  a decline in the cost of deoxyribonucleic acid (DNA) sequencing and  increases in genetically engineered crop development, expenditures in  research and development by biotechnology and pharmaceutical  companies, and demand for synthetic genes. On the other hand, bio- safety and bio-security concerns about the potential that synthetic biology  could be used for nefarious purposes may restrict the short-term growth  of synthetic biology.

Multiple Federal Agencies and Nonfederal Entities Support Quantum Computing and Synthetic Biology Research for Transformational Technological Advances

Multiple federal agencies and nonfederal entities support quantum  computing and synthetic biology research that could lead to  transformational technological advances in many areas of the U.S.  economy, including energy, medicine, and national security. We  identified 6 agencies that in fiscal year 2016 through the second quarter  of fiscal year 2018 supported quantum computing research to advance  foundational understanding of quantum computing or to develop related  hardware and software. We found that 4 of the 6 agencies reported a  combined total of at least $23.4 million in obligations to support quantum  computing research in fiscal year 2017. Similarly, we identified 10  agencies that, during the timeframe we reviewed, supported synthetic  biology research to advance foundational understanding of synthetic  biology or knowledge of how to apply it in bioengineering, national  security, and biofuels development. We found that 6 of the 10 agencies  reported a combined total of at least $211.2 million in obligations to  support synthetic biology research in fiscal year 2017. We also identified  a variety of nonfederal entities, such as universities and private  companies, that conduct research in quantum computing and synthetic  biology.

Six Agencies Support Research in Quantum Computing

In fiscal year 2017, 6 agencies—DOD, DOE, ODNI, NASA, Commerce’s  NIST, and NSF—supported quantum computing research, and 4 of these  6 agencies reported a combined total of at least $23.4 million in  obligations toward those efforts. Agency officials, stakeholders, and  experts we interviewed told us they expect quantum computers could  lead to transformational advances in national security technologies or in  technology areas that rely heavily on simulation, such as machine  learning for defense capabilities, pharmaceuticals, and materials science  for advanced manufacturing. However, there is still uncertainty  surrounding the specific applications of quantum computing. Agency  officials, stakeholders, and experts told us that they anticipate that  quantum computing applications may include large number factoring,  optimization of certain tasks, and simulation of other quantum systems.  Accordingly, agencies’ quantum computing efforts included research to  advance foundational understanding of quantum information science as  well as research to develop the hardware and software needed to build a  universal quantum computer.

Foundational Understanding of Quantum Information Science

Joint Quantum Institute (JQI)  The JQI is a research partnership between  the National Institute of Standards and  Technology and the University of Maryland,  with the support and participation of the  Laboratory for Physical Sciences. JQI was  created in 2006 to pursue theoretical and  experimental studies of quantum physics in  the context of information science and  technology. Among other objectives, JQI  conducts fundamental research on the  engineering and control of systems based on  quantum mechanics, which describes the  behavior of matter and energy at the smallest  physical scales. One attribute of quantum  physics is that certain properties of a particle,  such as its momentum and position, are not  fixed; instead these properties follow  probability distributions that describe the  likelihood a property may be a particular  value. Researchers have also discovered that  the quantum states of two separate objects,  like two atoms, can be entangled such that  the state of one object is correlated with the  other. This entanglement makes it possible to  move quantum information from one place to  another. The phenomena that occur at the  quantum scale have the potential to affect  disparate economic sectors and could lead to  improvements in computing and materials  science, among others. For example,  researchers at JQI have devised a new chip  that generates and steers single photons,  which could allow researchers to  systematically assemble pathways for single  photons and enable new types of optical  devices.  An illustration of a photonic chip created by  JQI researchers. and Revolutionary Computing program, NSF supports theoretical and  experimental research on quantum-based computing paradigms,  information, transmission, and manipulation. Also, the NSF Physics  Division’s Physics Frontiers Centers program supports university- based centers and institutes in enabling transformational advances  through interdisciplinary research across different areas of focus. One  of the Physics Frontier Centers that NSF supports is located at the  JQI; this center supports research that focuses on studying the  controlling and monitoring of quantum phenomena to support  quantum engineering. A second Physics Frontier Center is at JILA.  Both the JQI and JILA represent partnerships between the NSF and  NIST.

DOE’s Office of Science supports foundational quantum computing research as part of its Advanced Scientific Computing Research program, which focuses on discovering, developing, and deploying computational and networking capabilities to analyze, model, simulate, and predict complex phenomena important to DOE and the advancement of science. The program’s efforts include partnering with other Office of Science program offices to support research aimed at understanding how future computing technologies, including those based on quantum information science, could impact DOE’s  mission.

NASA’s Quantum Artificial Intelligence Laboratory—a collaborative effort with Google and the Universities Space Research Association— supports foundational research to maximize utilization of emerging quantum hardware. This work involves analytical and experimental research on the mechanisms underlying quantum computing, including, for example, researching quantum entanglement and measurement-based quantum computation. NASA also supports university-based quantum computing research through programs such as the Established Program to Stimulate Competitive Research (EPSCoR).

Lincoln Laboratory’s Quantum Computing  Laboratory  The Massachusetts Institute of Technology’s  Lincoln Laboratory is a federally funded  research and development center sponsored  by the Department of Defense that researches  and develops a broad array of advanced  technologies to meet critical national security  needs. In the area of quantum information  science, researchers with Lincoln Laboratory’s  Quantum Computing Laboratory are exploring  the fundamentally different ways that  information can be stored and manipulated  through quantum physics. Specifically, Lincoln  Laboratory researchers are working to  develop and scale up two systems that could  comprise the quantum bits, or “qubits” of a  quantum computer. In one method, called  Josephson junction-based superconducting  circuits, Lincoln Laboratory researchers are  using cryogenic dilution refrigerators and  microwave test and measurement equipment  to control and measure superconducting  qubits at extremely cold temperatures. In  another method, researchers are using  cryogenically cooled vacuum systems to  house micro-fabricated chips that trap  individual strontium and calcium ions, which  are manipulated using lasers and other  electromagnetic fields. For both methods,  researchers are working to scale up systems  of qubits to a size large enough to address  real computational problems.  Laser light manipulation of trapped ion qubits  at Lincoln Laboratory. broader portfolios of research across the department. For example, as part of DOD’s Applied Research for the Advancement of Science and Technology Priorities program, the Office of the Secretary of Defense administers the Quantum Science and Engineering Program—a cross-cutting effort that has supported research related to technologies for controlling qubit entanglement, among other things. Additionally, DOD supports a research program on Quantum System Sciences at Lincoln Laboratory, a federally funded research and development center operated by the Massachusetts Institute of Technology (MIT). This research encompasses, among other topics, development of quantum-based computation technologies.

DOE’s quantum science research efforts, such as those supported by the Office of Science’s Advanced Scientific Computing Research program, includes quantum computing hardware and architecture. After DOE issued its 2015 report on quantum computing for science, the agency held a February 2017 workshop to obtain information from stakeholders on the opportunities and challenges in establishing a quantum testbed to advance quantum computing hardware.Subsequently, DOE issued solicitations in 2017 and 2018 for proposals to support developing quantum testbeds. According to an April 2018 announcement for one of these solicitations, a testbed laboratory will host experimental quantum computing platforms that are not yet ready for commercialization, and will function as a collaborative facility to provide internal and external researchers with access to novel, early-stage quantum computing resources.

NIST’s quantum science research efforts include projects within its Physical Measurement Laboratory that are looking at a spectrum of potential quantum computing hardware approaches, such as superconducting circuits or ion trap-based quantum computing, that could provide viable approaches for processing and manipulating quantum information. By working across multiple approaches, NIST has been able to apply different quantum hardware platforms to  address computing and metrology problems, including creating one of  the most advanced ion trap-based quantum computing platforms.  Furthermore, NIST is using its advanced microfabrication facilities to  develop a broad array of components that will enable the scaling of  different quantum computing hardware platforms.

ODNI, through the Intelligence Advanced Research Projects Activity’s (IARPA) Logical Qubits Program, is supporting research to overcome the limitations of current multi-qubit systems, whereby qubits are impacted by other qubits, environmental factors, and other forces, which can generate errors in quantum computing operations. IARPA’s Logical Qubits Program is sponsoring research teams to build qubit structures with reduced susceptibility to these types of problems and has developed a quantum system with between 10 and 20 qubits.

NSF supports research related to quantum computing hardware as part of a broader portfolio of research under its Computing and Communication Foundations Division, which supports research that explores the foundations of computing and communications devices and their usage, including advancing hardware designs for computers and computational sciences, among other focus areas. For example, under the division’s Expeditions in Computing program, which provides financial assistance awards of up to $10 million over 5 years, NSF provided an award for the Enabling Practical-Scale Quantum Computation project in 2018. This project is a multi-institution, university-based effort to build a 100-qubit computer.

Agency officials, stakeholders, and experts said one area in which a  quantum computer could offer potential benefits over a classical computer  is solving optimization problems. However, using a quantum computer for  this or other applications requires developing software to, for example,  translate algorithms into the steps to manipulate qubits to perform  computing operations. Among the six agencies that support quantum  computing research, examples of agencies’ efforts to support research to  develop software necessary to operate a quantum computer include the  following:

DOD’s Air Force Research Laboratory issued a multi-year funding opportunity announcement for research on Quantum Computing Sciences with a focus on quantum computing algorithmic implementation and problem solving. Among other potential research topics, the Air Force is seeking research proposals to develop new algorithms to help solve optimization and machine learning problems.

NASA’s Advanced Supercomputing Division provides funding for the Quantum Artificial Intelligence Laboratory. Through this effort, NASA hosts a 2,031-qubit D-Wave 2000 quantum device. NASA researchers are using this system to explore the potential for quantum computers to tackle optimization problems that are difficult or impossible for traditional supercomputers to handle and to explore the software algorithms that would be needed to do so.

Ten Agencies Support Research in Synthetic Biology

In fiscal year 2017, 10 agencies—DOD, DHS, DOE, EPA, HHS, ODNI,  NASA, NIST, NSF, and USDA—supported synthetic biology research,  and 6 of these agencies reported a combined total of at least $211.2  million in obligations toward those efforts. According to one agency official  and experts, although synthetic biology has advanced significantly,  foundational understanding is still needed in some key areas, including  measurement and tool development. Accordingly, synthetic biology  research that federal agencies supported included research to advance  foundational understanding of the science, and the application of  synthetic biology in specific areas, such as bioengineering, genome  editing, national security, and biofuels and bioproduct development.

Foundational Understanding of Synthetic Biology

Genome in a Bottle  The Genome in a Bottle consortium is one of  several ongoing collaborations among the  National Institute of Standards and  Technology, Stanford University, and other  partners in the Joint Initiative for Metrology in  Biology. The initiative focuses on  measurements and standards supporting the  newest developments in genomics and  synthetic biology. The Genome in a Bottle  consortium focuses on genome sequencing,  which involves determining the chemical  building blocks of deoxyribonucleic acid  (DNA) or ribonucleic acid (RNA) and can give  insights into the genes carried by an individual  and how and when they are activated. Since  the completion of the Human Genome Project  in 2003 that first sequenced the whole  genome of a human, scientists have worked  to make whole human genome sequencing  faster and less expensive. The consortium  aims to develop the tools needed to ensure  the accuracy of human genome sequencing.  These tools include reference materials,  standards, and data to enable the translation  of whole human genome sequencing to  clinical practice.  Illustration of a chromosome inside a bottle.

NIST supports foundational synthetic biology research by developing measurement solutions, serving as a neutral ground for the discussion of underpinning measurements and other manufacturing needs, and leading and contributing to the development of standards. NIST measurement infrastructure includes the development of enabling tools, methods, and protocols; bioinformatics and modeling tools; and documentary standards and reference materials. NIST also leads several consortia to work with measurement stakeholders and partners to accelerate breakthroughs in genomics and synthetic biology. These include NIST’s Genome in a Bottle consortium and the Joint Initiative for Metrology in Biology.

DOE supports foundational research related to synthetic biology as part of a broader portfolio of research under the Biological and Environmental Research (BER) Genomic Science program, which seeks to understand how genomic information is translated to functional capabilities, enabling more confident redesign of microbes and plants for sustainable biofuel production, improved carbon storage, or contaminant bioremediation. Within BER, DOE funds the Joint Genome Institute to produce high-throughput sequencing, a fast method of determining the order of bases of genetic material, synthesis and analysis in support of BER’s bioenergy and environmental missions. Research enabled through this user facility includes developing renewable and sustainable sources of biofuels from plant biomass and exploring the biological processes controlling greenhouse gas accumulation in the atmosphere.

Within HHS, multiple NIH institutes and centers support foundational research involving synthetic biology techniques, including NIH Common Fund support for research to understand and combat antibiotic resistance and National Cancer Institute support for research into new cancer immunotherapy methods. Additionally, the National Institute of Biomedical Imaging and Bioengineering has provided grants to researchers studying or using a multitude of synthetic biology techniques for applications, such as improving stem cell quality for biomedicine.

NSF funds an estimated $60 million a year in foundational synthetic biology research across several directorates. For example, in 2013, NSF awarded a 5-year, $10 million Expeditions in Computing grant for a multi-university effort led by the California Institute of Technology to  enable theoretical investigations in several synthetic biology-related  topic areas. In 2016, NSF awarded a second 5-year, $10 million  Expeditions in Computing grant for a multi-university effort led by  Boston University to support synthetic biology research.

Gene Editing  The National Institutes of Health (NIH)  describes gene editing as a group of  technologies that give scientists the ability to  add, remove, or alter genetic material at  particular locations in the genome. One such  technology is known as CRISPR-Cas9, which  is short for clustered regularly interspaced  short palindromic repeats and CRISPR- associated protein 9. According to NIH, the  CRISPR-Cas9 system has generated  excitement in the scientific community  because it is faster, cheaper, more accurate,  and more efficient than other existing gene  editing methods. The system was adapted  from a naturally occurring gene editing system  that helps bacteria defend themselves against  viruses by targeting the deoxyribonucleic acid  (DNA) of the virus. In the lab, CRISPR-Cas9  allows researchers to cut out a specific  sequence of DNA from cells. Once  researchers cut out the targeted DNA  sequence, they can use other techniques to  add or delete genetic material. These genetic  changes can cause the edited cells to express  new physical traits, such as eye color, or  change their disease risk. Gene editing is  being applied to research on many diseases;  however, according to NIH, there are still  significant technical barriers to using gene  editing therapies to treat human diseases.  Further, the use of gene editing raises a  number of ethical concerns.  An illustration of a chromosome unravelling to  show the DNA that makes up individual  genes.

Development programs are developing on-demand nutrients from  microbes engineered to produce targeted nutrients for human  consumption as well as examining how to manipulate certain types of  bacteria to produce lightweight construction tools and materials.

EPA employs synthetic biology approaches through its Chemical Safety for Sustainability Research Program, which seeks to develop new prediction techniques, pioneer the use of innovative technologies for chemical toxicity testing, and design tools to advance the management of chemical risks. For example, researchers are developing virtual tissues by building complex computer models for biological development. According to an EPA publication, the models will help reduce dependence on animal study data and provide faster chemical risk assessments.

NSF’s Science and Technology Center Program’s Center for Cellular Construction seeks to develop tools to predict, design, and test the impact on cellular function of changes to cells’ internal organization. The center will also develop living “bioreactors” that will generate products of commercial value. NSF has funded research into bacterial immunity, which led to the development of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9—a technology that allows researchers to precisely edit genes.

Several NIH institutes and centers support research related to bioengineering. For example, NIH’s Synthetic Biology for Engineering Applications Funding Opportunity Announcement solicits applications to support research to advance the understanding and application of synthetic biology for human health. In addition, NIH institutes and centers have supported research across various areas, including engineering synthetic receptor systems and genetic controller circuits, engineering microbes as therapeutic platforms, and developing enabling technologies for human-machine hybrid tissues.

Application of synthetic biology may support U.S. national security efforts  by aiding with monitoring for biological or conventional threats, and  strengthening the resilience of soldiers in combat. Among the 10  agencies that support synthetic biology research, officials from DOD,  ODNI, and DHS said their agencies support synthetic biology research  with potential national security applications. Examples of federal efforts in  this area include the following:

DOD’s Office of Naval Research funds research to extend the natural capabilities of living organisms such as microbes and plants to create systems that will provide new naval capabilities, according to the office’s website. Office of Naval Research officials told us the office is funding ongoing research related to engineering gut microbes in order to enhance the resilience of service members to deployment stressors, among other things. In addition, DARPA’s Safe Genes Project supports force protection and military health and readiness by protecting service members from accidental or intentional misuse of genome-editing technologies. For example, researchers are developing the genetic circuitry and genome-editing machinery for robust, spatial, temporal, and reversible control of genome-editing activity in living systems.

ODNI supports synthetic biology research through efforts including IARPA’s Functional Genomic and Computational Assessment of Threats program, which supports research to protect against critical threats related to pathogens and other biological threats. Researchers aim to develop better approaches and tools for characterization and analysis of biological threats based on gene function.

DHS’s Biological Threat Characterization program and its Biodefense Knowledge Center program support synthetic biology research to understand the risks associated with the technologies useful for synthetic biology and the harmful pathogens that may be created by those who wish to do harm.

Synthetic biology is being used to develop cost-effective methods for  producing biofuels and bioproducts according to agency officials, experts,  and DOE’s website. Among the 10 agencies that support synthetic  biology research, officials from DOE and USDA said their agencies  support synthetic biology research related to biofuels development  applications. Examples of federal efforts in this area include the following:

DOE officials told us that the Office of Energy Efficiency and Renewable Energy’s Bioenergy Technologies Office manages the Conversion Program and the Advanced Algal Systems Program, both of which employ synthetic biology techniques to accomplish office goals. Within the Conversion Program, DOE funds the Agile BioFoundry to help develop and transition synthetic biology tools from the laboratory to the biofuels and bioproducts industry. The program accomplishes this through targeted research and development partnerships with industry and academia, as well as by developing integrated synthetic biology tools designed to speed up biomanufacturing. In addition, the office funds the Advanced Algal Systems Program, which supports early-stage applied research to apply synthetic biology approaches to alternative fuels that use algae as their source, among other things. According to a DOE website, this industry has the capability of producing billions of gallons per year of renewable diesel, gasoline, and jet fuel.

USDA, through the Agricultural Research Service, led a collaborative project between federal, industry, and academic researchers to produce a commercial rubber-based tire using the guayule plant, a small shrub native to the United States that has been considered a possible alternative source of natural rubber.

Nonfederal Entities Support Research in Quantum Computing

Nonfederal research to advance quantum computing includes efforts to  address existing hardware and software challenges. We identified a  variety of nonfederal entities, such as universities and private companies,  that have ongoing efforts aimed at building a quantum computer.  Stakeholders we spoke to told us that private companies have been  increasing their research in quantum computing.

Academic and industry stakeholders we interviewed described various  efforts to develop the hardware needed for a quantum computer.  Examples of ongoing efforts include the following:

Academic researchers at Purdue University partner with Microsoft at Station Q-Purdue to perform a variety of experiments and activities related to building a semiconductor-based quantum computer, including testing different hardware designs.

Academic researchers from Yale’s Quantum Institute are working to develop scalable superconducting devices.

Researchers at IonQ are working to develop general-purpose quantum information processors using a trapped-ion approach to create a quantum computer that is scalable and that could support a broad array of applications across a variety of industries.

A Google official told us that the company has been working for several years to build a quantum computer through the Quantum Artificial Intelligence Lab. In a March 2018 press release, Google announced its newest 72-qubit quantum computer, called Bristlecone.

Academic and industry stakeholders we interviewed described ongoing  efforts related to software development. Examples of ongoing efforts  include the following:

An official from Microsoft said the company is working to develop quantum algorithms and software to run on a quantum computer for a given set of problems. Researchers are also currently developing an operating system and various applications that could be run on a quantum device.

An IBM official told us that, in 2016, the company launched the Quantum Experience, a quantum computing system with five superconducting qubits on the cloud, encouraging students and researchers worldwide to explore quantum computing. Over the past two years, the system’s software has been expanded and upgraded for greater functionality and exploration of quantum algorithms to allow researchers around the world to use the system to write more than 80 research publications. MIT and many other universities now  use the Quantum Experience in their curricula.

Nonfederal Entities Support Research in Synthetic Biology

We identified a variety of nonfederal entities, such as universities and  private companies, that conduct research in synthetic biology to advance  foundational understanding and develop new products.

The iGEM Foundation  The International Genetically Engineered  Machine (iGEM) Foundation is an  independent, non-profit organization  dedicated to the advancement of synthetic  biology, education and competition, and the  development of an open community and  collaboration. The foundation does these by  fostering an open, cooperative community and  friendly competition. The main iGEM program  is the iGEM competition, which began in  January 2003 as an independent study  course at the Massachusetts Institute of  Technology in which students developed  biological devices to manipulate cells. This  course became a summer competition with 5  teams in 2004, grew to 13 teams in 2005, and  had expanded to 310 teams by 2017,  reaching more than 40 countries. The  competition was originally aimed at college  students but has expanded to include high  school students and others. The iGEM  competition gives students the opportunity to  push the boundaries of synthetic biology by  tackling everyday issues facing the world.  Multidisciplinary teams made up of primarily  university students work together to design,  build, test, and measure a system of their own  design using interchangeable biological parts  and standard molecular biology techniques.  Every year nearly 6,000 people dedicate their  summer to iGEM and then come together in  the fall to present their work and compete at  the annual Jamboree.  A picture of the iGEM logo.

The International Genetically Engineered Machine (iGEM) Foundation hosts an annual worldwide synthetic biology competition in Boston, the iGEM Giant Jamboree. The competition attracts teams from around the world (primarily university students) to use standardized genetic parts to address real-world problems in fields including health, medicine, manufacturing, and bioenergy.

At MIT’s Synthetic Biology Center, researchers work with federal and industry partners to advance understanding of synthetic biology for genetic programming, DNA synthesis, and genome design. Researchers at the Synthetic Biology Center seek to create a programming language for living cells that is similar to languages used to program computers and robots.

Development of New Products and Technologies

DNA Storage  To facilitate storing an ever-increasing amount  of digital data, researchers from Microsoft, in  collaboration with the University of  Washington, are studying the use of synthetic  deoxyribonucleic acid (DNA) as a means of  storing data. According to a Microsoft  researcher, this technology uses a process by  which custom sequences of synthetic DNA  are produced or manufactured to store  information. The researcher described three  main advantages of storing data in DNA as  compared to the current means of storing  data, generally magnetic and optical media:  Density. DNA may allow for the storage of up  to 1 exabyte (one quintillion bytes) of data  per cubic millimeter. In comparison,  according to Microsoft, storing similarly  large volumes of data in optical discs  would occupy significant physical space.

IBM researchers are developing biosensors that may be used for the early detection of cancer. They are also working on understanding and analyzing cardiac, neurological, and mental health conditions.

Researchers from Microsoft said the company is conducting research related to data storage using synthetic DNA as the information preservation medium. This storage technology uses a process by which custom sequences of synthetic DNA are manufactured to store information.

Ginkgo Bioworks officials said the company is focused on trying to de- risk supply chains and improve supply chain management through  synthetic biology approaches. To that end, the company designs  custom enzymes for a variety of customers including companies in a  wide range of industries such as food and fragrance companies. relevant storage mechanism, unlike other  means of storing digital data (e.g., floppy  discs), which becomes outdated as  technology advances.

The Energy Biosciences Institute is a partnership among the  University of California, DOE’s Lawrence Berkeley National Lab, and  the University of Illinois. Researchers at the Energy Biosciences  Institute carry out research in the areas of biofuels, carbon  sequestration, and sustainable chemicals productions, among other  things.

Agencies Coordinate Research through a Range of Efforts, but Interagency Groups Have Not Fully Implemented Selected Leading Practices

Agency officials we interviewed said they coordinate on quantum  computing and synthetic biology research through a range of efforts, but  we found that certain efforts are new and that agencies have not fully  implemented selected leading practices for collaboration in these efforts.  Agency officials told us they use means of coordination ranging from  attending ad hoc meetings, such as conferences or workshops, to  participating in ongoing interagency groups, such as interagency groups  on quantum information science (QIS) and synthetic biology. However,  we found that new interagency groups on QIS and synthetic biology have  not fully implemented leading practices that can enhance and sustain  collaborative efforts.

Agencies Coordinate on Quantum Computing and Synthetic Biology Research Using Efforts That Range from Ad Hoc Meetings to Ongoing Interagency Groups

Agency officials said that they coordinate on quantum computing and  synthetic biology research by attending ad hoc meetings, as well as  through ongoing efforts such as participating in interagency working  groups. The means of coordinating that officials most frequently cited  were participating in working groups or attending a conference or  workshop. Meetings such as these bring together representatives of  different agencies or departments to discuss common problems,  exchange information, or develop agreements on issues of mutual  interest, as we have reported in the past. Specifically:

Officials from 4 of the 6 agencies that support quantum computing research said they attended a conference or workshop related to quantum computing at some point from October 2015 through March 2018. For example, NASA and DOE officials participated in a 2017 NASA workshop that brought together experts from NASA research centers, DOE national laboratories, academia, and industry to discuss quantum information science and computation.

Officials from all 10 agencies that support synthetic biology research cited attendance at a conference, and officials from 7 of these 10 cited workshops as a way in which they coordinated on synthetic biology research from October 2015 through March 2018. For example, officials from DOD, DOE, NIST, and national laboratories attended a 4-day conference in June 2017 to discuss synthetic biology applications in genetic engineering.

Officials from 7 of the 10 agencies that support synthetic biology research also said they coordinated research with other selected agencies through communities of practice or consortia that meet on an ad hoc basis. For example, NASA officials said they support synthetic biology work through the Space Technology Research Institute in Biomanufacturing, a University of California Berkeley-led consortium of universities.

Officials we interviewed also said they coordinate with one another  through ongoing efforts, such as interagency groups. For example, on  June 21, 2018, NSTC established the Subcommittee on Quantum  Information Science (QIS Subcommittee) to coordinate quantum  computing research. According to its June 2018 charter, the QIS  Subcommittee’s purpose is to establish and maintain a national agenda in  quantum information science and technology, expand U.S. economic and  national security, and coordinate federal quantum information science  and technology policy and programs. The functions of the QIS  Subcommittee include to  issue and update plan(s) that coordinate(s) federal policy to expand U.S. leadership in quantum information science and technology; enable stakeholders to invest effectively in quantum information science and technology and post-quantum application spaces through data gathering, analysis, consultation, planning, convening, and reporting; and provide a forum for research and development coordination and collaboration, including sharing expertise and best practices for program management and conducting joint workshops and program reviews.

The QIS Subcommittee is led by co-chairs from NIST, DOE, NSF, and  OSTP and includes 9 additional agencies. The QIS Subcommittee met  for the first time as an official chartered group on June 28, 2018. The  OSTP official serving as a co-chair for the QIS Subcommittee said that  the group’s first priority will likely be to develop a national approach to  QIS research and development.

Officials from 5 of the 6 agencies that support quantum computing  research said that prior to the formation of the QIS Subcommittee, they  coordinated through the NSTC Interagency Working Group on Quantum  Information Science (QIS working group), which was formed in 2014. In  July 2016, the QIS working group produced a report, which the agency  officials serving as the group’s co-chairs told us included its strategic plan  for federal QIS research. The July 2016 report identified QIS as a  priority for federal coordination and investment as a component of U.S.  scientific leadership, national security, and economic competitiveness.  The QIS Subcommittee co-chair from OSTP said that the shift from a  working group to a subcommittee is a significant elevation that  communicates the importance of QIS to the administration.

Agencies also coordinated synthetic biology research through interagency  working groups. Officials from NSF and USDA told us that, in December  2017, they formed a new synthetic biology working group that had 7  member agencies as of February 2018. These officials said that the  participating agencies saw a need for continued communication and  information sharing, and the officials said the group’s efforts will increase  coordination. Prior to the formation of this new group, 7 of the 10  agencies that support synthetic biology research participated in an NSTC  Synthetic Biology Working Group that NSF officials said existed from  2012 to 2013 and was co-chaired by DOD and DOE, according to a  2013 DOE report to Congress that the group produced. According to  some officials, the working group ended after it produced this report,  which described synthetic biology research and development needs at  the time and identified which federal agencies were planning synthetic  biology research. The report also discussed the need for communication  and coordination among federal agencies that support basic and applied  synthetic biology research to build synergies, consider new research and  development needs, and evaluate issues as they emerge. According to a  senior NSF official we interviewed who was helping lead efforts to  establish the new group, one of its first undertakings will be to update the  2013 report to provide a roadmap for agencies’ synthetic biology  research. However, the official also stated that the participating agencies  were still considering the new group’s activities.

Agencies Are Coordinating on Quantum Computing and Synthetic Biology through New Interagency Groups, But Have Not Fully Implemented Leading Collaboration Practices

By recently establishing the QIS Subcommittee and a synthetic biology  working group, NSTC and federal agencies, respectively, took steps to  further coordination on quantum computing and synthetic biology  research. However, the new subcommittee and working group have not  fully implemented leading practices for collaboration.

We have reported that effective collaboration can help reduce or better  manage fragmentation, overlap, and duplication of federal programs. As  described above, a number of federal agencies support research related  to quantum computing and synthetic biology. In our April 2015 guide to  evaluating and managing fragmentation, overlap, and duplication, we  define fragmentation as those circumstances in which more than one  federal agency, or organization within an agency, is involved in the same  broad area of national need, and opportunities exist to improve service  delivery. This definition applies concerning federal agencies’ quantum  computing and synthetic biology research, with more than one agency  involved in the same broad area of national need. However, as shown in  our description above of the agencies’ support for research in these two  areas, agencies’ activities sometimes differ in meaningful ways or  leverage the efforts of other agencies.

We examined agencies’ efforts to coordinate through interagency groups  by selecting six leading practices that we have previously identified can  enhance and sustain interagency collaboration:

Define and articulate a common outcome. Effective collaboration requires agencies to define and articulate common outcomes or purposes they are seeking to achieve that are consistent with their  respective agencies’ goals and missions.

Establish mutually reinforcing or joint strategies. Having mutually reinforcing or joint strategies enables agencies to align activities, core processes, and resources to achieve a common outcome.

Identify and address needs by leveraging resources. Agencies can sustain their collaborative efforts by identifying the human, information technology, physical, and financial resources necessary to achieve identified outcomes.

Agree on roles and responsibilities. By defining and agreeing on roles and responsibilities, including leadership, collaborating agencies can better clarify who will do what, organize their joint and individual efforts, and facilitate decision making.

Establish compatible policies, procedures, and other means to operate across agency boundaries. Agencies can facilitate collaboration by addressing the compatibility of standards, policies, procedures, and data systems that will be used in the collaborative effort.

Develop mechanisms to monitor, evaluate, and report on results.

Creating the means to monitor and evaluate collaborative efforts enables agencies to identify areas for improvement.

We identified limitations in agencies’ past efforts to coordinate quantum  computing and synthetic biology research. In the area of quantum  computing, the QIS working group—which preceded the subcommittee— took steps to implement selected leading practices for collaboration, but  the group did not fully implement these practices. For example, the QIS  working group’s July 2016 report broadly identified quantum computing  research needs but did not identify common outcomes for agencies’  collaborative efforts to advance QIS, including quantum computing. The  three senior officials who served as co-chairs of the QIS working group  said they were not aware of any federal goals or outcomes for quantum  computing research, and DOE officials said that clarifying common goals  could help interagency collaboration on quantum computing research.  Officials from some agencies cited challenges with collaborating on joint  quantum computing projects—for instance, because of variations among  agencies on time frames for providing financial assistance.

OSTP officials described the establishment of the QIS Subcommittee as  an effort to further previous coordination conducted through the QIS  working group. While the QIS Subcommittee has taken initial steps to  implement certain leading practices for collaboration, it has not fully  implemented the relevant leading collaboration practices we identified.  For example, by developing a charter that identifies its high-level purpose  and functions and that identifies co-chairs for the group, the QIS  Subcommittee has taken initial steps to identify some agencies’ roles and  to establish means for operating across agency boundaries. Moreover, by  having a charter signed by senior officials, the QIS Subcommittee has  taken steps to document agencies’ agreement to collaborate, which is a  key feature of collaborative mechanisms we have identified in our prior  work. However, the working group has not defined roles and  responsibilities for agencies other than the co-chairs. OSTP officials said  that efforts to date have focused on ensuring that all relevant agencies  are included in the QIS Subcommittee; the officials also said that  agencies’ roles and responsibilities for contributing to the subcommittee  will evolve. Table 1 provides additional information on the extent to  which the QIS Subcommittee has implemented leading practices for  collaboration.

With regard to interagency coordination on synthetic biology research,  NSF and USDA officials noted that the new synthetic biology working  group hoped to, through continued communication and information  sharing, address limitations in agencies’ coordination that existed prior to  its formation. Officials from NSF said the group was needed for  communication, information sharing and to leverage resources and DOD  officials agreed that the working group was needed. Additionally, one  DOD official and one expert said that limited interagency coordination had  resulted in lost opportunities to further develop the area of synthetic  biology. They also noted that having a national strategy for synthetic  biology would be beneficial. Other officials noted that, as in the area of  quantum computing, differences in funding timeframes across agencies  hinder their ability to coordinate their synthetic biology research. Some of  these officials also said such differences make it difficult to develop an  integrative roadmap for their research.

Like the QIS Subcommittee, the new synthetic biology working group has  taken initial steps to implement some leading practices for interagency  collaboration but has not fully implemented the relevant leading  collaboration practices we have identified. For example, the group has  taken initial steps to identify member agencies’ roles by having NSF serve  as the lead agency for the first 2 years. However, the group has not  identified other member agencies’ roles and responsibilities. An NSF  official said the new working group had also considered developing a  document, such as a charter, to guide its efforts but, as of June 2018, it  had not yet decided whether to do so. Table 2 provides additional  information on the extent to which the Synthetic Biology Working Group  has implemented leading practices for collaboration.

As we previously reported, interagency collaborative mechanisms can  take many different forms, such as working groups or subcommittees,  and the leading practices we identified that help enhance and sustain  interagency collaboration can be adapted to help address the specific  challenges agencies face. For example, incorporating the leading  practices into agencies’ collaborative efforts can help address issues  associated with potential fragmentation, overlap, and duplication in  instances where multiple agencies have activities in a similar area. The  QIS Subcommittee and the synthetic biology working group are  mechanisms through which agencies can address limitations in past  interagency coordination on quantum computing and synthetic biology.  However, as of July 2018, the subcommittee and working group were still  new and have had limited time to fully implement the leading practices we  have identified. As the subcommittee and the working group move  forward, by taking steps to fully implement these leading practices,  member agencies could better marshal their collective efforts to support  research in the areas of quantum computing and synthetic biology and  help maintain U.S. competitiveness through transformational  technological advances.

Experts Identified Key Considerations for Maintaining U.S. Competitiveness through Transformational Technological Advances

Experts who participated in the meeting we convened with the assistance  of the National Academies identified four key considerations for  maintaining U.S. competitiveness through transformational technological  advances. These considerations extend beyond quantum computing and  synthetic biology, and more broadly address the role of federal and  nonfederal entities in supporting research for such advances. The key  considerations experts identified were (1) developing a strategic approach  for transformational technology, (2) fostering information sharing, (3)  focusing on technology development and commercialization, and (4)  strengthening the science and technology workforce.

Developing a Strategic Approach for Transformational Technology

Experts emphasized the importance of developing a strategic approach  for advancing potentially transformational technologies for maintaining  U.S. competitiveness. has a technological focus, such as additive manufacturing,  advanced flexible electronics, or regenerative medicine, and  includes members such as companies, nonprofit organizations,  academic institutions, and federal agencies.

Semiconductor Manufacturing Technology consortium (SEMATECH). Experts described SEMATECH, a nonprofit consortium that supported research and development on advanced semiconductor manufacturing, as a successful, industry-led, public-private collaboration that helped government and industry stakeholders take a strategic approach to challenges facing the U.S. semiconductor industry in the late 1980s.However, Commerce’s NIST officials noted that after federal support ended, SEMATECH began accepting memberships from companies from competitor countries, which led to a transfer of technology through the consortium’s work outside the United States. are industry-led and industry provides at least half of the annual funding because industry can best design a research program to meet its needs; develop a comprehensive industry assessment and prepare an operating plan that identifies realistic objectives and milestones as a basis for receiving federal funds; include active participation by member companies’ senior executives in establishing research priorities and overseeing technological progress; have a program to improve long-term working relationships between manufacturers and key suppliers, unless inappropriate for the industry’s structure; emphasize research projects that improve an industry’s overall efficiency and that have industrywide applications; consider ways to provide access for smaller industry members that might not have the resources to participate; and establish criteria for determining how or when government should end its funding.

Grand challenges, strategies, and roadmaps. Experts described the importance of grand challenges, strategies, and roadmaps in supporting a strategic approach to developing transformational technologies. In particular, experts described how these mechanisms help stakeholders coalesce around technology goals and organize efforts toward reaching them. Examples experts noted included the following:

Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. Experts described the BRAIN Initiative, which was launched in 2013 to build neuroscience measurement tools, as a key example of a grand challenge. The BRAIN Initiative—led by HHS (specifically NIH), NSF, and DARPA, with the participation of other federal agencies as well as foundations, universities, and industry—seeks to deepen understanding of the human mind and to improve how brain disorders are treated, prevented, and cured.

National Nanotechnology Initiative. Experts described the National Nanotechnology Initiative as a key example of a federal government strategic effort. The National Nanotechnology Initiative began in 2000 and is an interagency effort to bring together the nanotechnology-related activities of 28 federal agencies in an effort to enhance understanding and control of nanoscale material. The National Nanotechnology Initiative maintains a strategic plan describing the initiative’s vision and goals and the strategies to achieve these goals. In discussing this initiative, experts described how it could enable federal agencies  to share information on their research and ensure that key  research areas are advanced in pursuit of a long-term national  nanotechnology strategy.

Grand challenges may be articulated through strategy documents  and, according to experts, involve getting stakeholders to think about  potentially transformational technologies in a future-oriented way.  Roadmaps, according to experts, represent detailed plans to guide  progress toward a technology goal. Federal agencies, industry, or  others may lead roadmapping efforts, according to experts.  Additionally, one expert stated that roadmaps can help accelerate  technology development. Another expert noted that for some fields,  such as quantum computing and synthetic biology, a technology  development strategy is needed in addition to a research and  development strategy because the former outlines how a technology  would move forward beyond the research and development phase.

Across both of these aspects of a strategic approach, experts  emphasized the importance of a sustained commitment of resources to  support technology development. One expert also emphasized the  importance of setting tough performance objectives without specifying  how innovators will solve a problem. Experts acknowledged that  developing shared national strategies is challenging in the United States,  in part because of the decentralized nature of research support across  multiple federal agencies. However, experts also cited as strengths of  the federal research system the ability of federal agencies to support  multiple approaches to developing transformational technologies in  accordance with their missions and the ability to evolve and try new  approaches.

Experts identified several indicators of when developing a strategic  approach might be important to support U.S. competitiveness through  transformational technological advances in a particular area. Specifically:

Convergence of advances across different technology areas.

Experts described how transformational technologies often occur as a result of different technologies that have advanced incrementally over time. One expert noted the development of the Global Positioning System as an example of a technology that required the convergence of advances in computing power, satellite technology, geospatial imaging, and timekeeping. Because of the strength and role of the federal government in convening and fostering engagement among non-traditional collaborators on interdisciplinary issues, experts identified technology convergence as a potential indicator of the need to take a strategic approach.

Progress from discovery to real-world application. Experts described how progress from discovery in an area of science to the appearance of niche applications for a technology can be an indicator of the need to take a strategic approach. According to one expert, one challenge in technology development is how to push the technology forward as quickly as possible to develop it into something useful. Experts explained that by taking a strategic approach that extends beyond early-stage research, the federal government can support the development of potentially transformational technologies.

Existence of barriers to technology development. Experts identified several barriers to the development of transformational technologies that could indicate the need to take a strategic approach to developing a technology. Examples of barriers experts identified included high capital costs for research, prototyping, demonstration, or other aspects of a technology development life cycle; regulatory barriers; lack of consensus on standards; and technology measurement challenges, such as limitations in the availability of tools with which to measure products or processes. Experts described multiple ways in which the federal government can play an important  role in addressing such barriers through helping efforts to de-risk  technologies, establishing or revising regulations, supporting  standards development, and developing measurement tools.

Increasing involvement across multiple stakeholders or competitors. Experts described aspects of how increasing involvement across multiple stakeholders in a particular technology area can indicate the need to take a strategic approach to developing a transformational technology. For example, when multiple federal agencies are working in a technology area or industrial participants increase involvement in a particular technology, experts said such involvement could signal that a strategic approach is needed to work across boundaries and engage the research community in a coordinated way. Similarly, according to one expert, increasing international competition in a technology area could serve as an indicator of the need for the federal government to exercise leadership through a strategic approach to organize domestic public and private efforts in order for the United States to remain competitive.

Need for sustained, long-term investment in areas of national interest. Experts identified the need for sustained, long-term investment in areas of national interest as a potential indicator of the need for a strategic approach to transformational technologies. Experts described how the short-term cycles of many federal programs and disincentives for the private sector to sustain long-term investments can present challenges to developing transformational technologies, which one expert noted can take years or even decades to develop. Experts also cited a need for a strategic approach to advancing a technology when it has the potential to be transformational and presents enormous societal benefits.

In the areas of quantum computing and synthetic biology, experts cited a  need to develop a strategic approach to maintain U.S. competitiveness.  Within the area of quantum computing, experts cited all of the indicators  identified above in stating that U.S. competiveness in quantum computing  could benefit from a national strategy. For example, experts described the  need to foster interdisciplinary engagement across the fields of physics,  engineering, and computer science to support convergence of advances  in these areas to further quantum computing technology. Experts also  indicated that real-world applications are beginning to become apparent  in the area of quantum computing. However, they noted that significant  barriers to development exist and discussed a need for sustained long- term investment in this area, which has significant implications for  national security, and according to one expert, economic  competitiveness. Moreover, experts expressed concern over the  significant and increasing international competition from China, the  European Union, and other countries. One expert noted that given the  security implications of quantum computing technology, the United States  needs to find a way to counter the significant investment that China is  making. Stakeholders and one agency official we interviewed cited similar  concerns, such as the European Union’s plans to launch a flagship  initiative on quantum technology, which includes quantum computing;  therefore, the United States needs a national quantum computing  strategy, the experts said.

Similarly, with regard to synthetic biology, experts cited several of the  indicators described above in stating that the United States could benefit  from a strategic approach to maintain competitiveness. For example,  experts discussed barriers to technology development, including a lack of  measurement tools and regulatory barriers. According to one expert,  before the 2017 update to the Coordinated Framework for the Regulation  of Biotechnology, the system was last updated in 1992. The expert said  that it was not yet clear if the updated framework would help advance  synthetic biology research. Experts also noted the need to engage across  multiple stakeholders in this area; in particular, one expert noted the need  for leadership to advance a dialogue about how synthetic biology could  help address issues of national concern. Experts described significant  foreign competition in synthetic biology. One expert said that there are  more than 40 countries that have a unified strategy for synthetic  biology. While one expert stated that NSF has initiated a synthetic  biology roadmapping effort, a few experts stated that the United States  does not have a similar unified synthetic biology strategy. One expert  said that in the absence of such a strategy, the United States faces  economic and physical security risks. Stakeholders we interviewed raised  similar concerns.

Experts also suggested considering how to foster information sharing to  help maintain U.S. competitiveness through transformational  technological advances. Experts discussed the role the federal  government can play in bringing together stakeholders to discuss  emerging technologies and collaborate on pre-competitive research. For  example, according to one expert, in 2015, 2 years after the BRAIN  initiative was launched, the White House convened a meeting that  brought together industry partners, academic researchers, and  government scientists to share information and discuss research plans.  This expert highlighted the importance of communication among  representatives of organizations that would not normally work together,  and how these conversations about where they saw research going over  the next 5 years led to greater understanding and collaboration to support  the research under this initiative.

Experts identified three key reasons for sharing information to facilitate  transformational technological advances in supporting U.S.  competitiveness:

Convergence of different disciplines. Experts generally agreed that information sharing can facilitate an interdisciplinary approach to study a problem, which they said is important to the nation’s ability to conduct research for transformational technological advances. The federal government’s ability to convene groups, according to one expert, is particularly important for interdisciplinary areas of study because it can help bring stakeholders together to discuss how research could help address an area of national need. Another expert explained that agencies’ research is increasingly interdisciplinary, which increases the importance of coordinating across agencies.Agency officials and stakeholders we interviewed also discussed the importance of sharing information across fields of study. One stakeholder said that without government funding for interdisciplinary efforts in quantum computing, it will be challenging to solve problems, such as creating some of the computer programming needed to operate a quantum computer, that need to be solved in order to make quantum computing viable.

Overcoming barriers to innovation. Experts discussed how information sharing can facilitate the identification of barriers to innovation and help overcome them. For example, one expert noted the importance of information sharing in trying to address the challenges the U.S. semiconductor industry faced in the 1980s. The expert emphasized the recognition that individual companies could not address the barriers to innovation on their own and that they needed information sharing, such as cross-licensing of intellectual property and communication about roadmapping to overcome barriers that they faced. Another expert explained that information sharing across federal agencies led to the identification of the U.S.  biotechnology regulatory system as a significant barrier to innovation  and that, based on this, the Coordinated Framework for the  Regulation of Biotechnology was updated. This expert further said  that information sharing is the first step in coordination—by sharing  information, agencies can determine where there might be  overlapping research efforts or gaps in ongoing research.

Leveraging international research. Experts explained that bringing technologies to the United States that were developed elsewhere is not something that has been central to U.S. science and technology policy, but they stressed that the United States needs to consider how to take advantage of research that other countries are conducting and effectively utilize that information to maintain U.S. competitiveness. For example, one expert described the importance of the iGEM competition as an opportunity for information exchange among researchers from around the world who are working in synthetic biology-related fields. In describing this example, the expert noted that most bioengineers will not be U.S.-based and that, to remain competitive in synthetic biology, the United States needs to better understand discoveries being made by researchers from around the world.

Experts said that while information sharing is important, there are  tradeoffs, particularly with regard to sharing and protecting pre- competitive intellectual property. The experts said that the benefits of  sharing pre-competitive intellectual property include the opportunity to  speed innovation by allowing multiple researchers to work with the  intellectual property concurrently and by preventing foreign competitors  from restricting use of the intellectual property through obtaining a patent.  Economically valuable knowledge can spread through publicly and freely  available records such as scientific publications and open source  software. Such knowledge can be used repeatedly, can quickly spread to  users outside the institutions where it was created, and can lead to the  creation of new products. For example, one expert stated that, as of   October 2017, a quantum computer we described earlier in this report  had been available over the Internet for public use for about a year and  had 50,000 users. Having a larger number of users working with this  resource could lead to more rapid discovery of ways in which a quantum  computer might be used than if it had not been shared. The expert said  that because this technology exists, it should be developed as quickly as  possible to determine what its first useful application will be and to find  the first problem that only a quantum computer can solve. Doing so, the  expert said, would create opportunities in which a U.S. company could  profit from the technology while also developing it. In addition, information  sharing was cited as instrumental to the success of the Human Genome  Project, according to NIH officials we interviewed, because the project  made the genome’s sequencing available as a resource for researchers  to use.

A deoxyribonucleic acid (DNA) strand around  the outline of a person.  The Human Genome Project, which formally  began in 1990, was a 13-year international  collaborative research project coordinated by  the Department of Energy and the National  Institutes of Health. The Human Genome  Project’s goals were to (1) identify all the  genes in human DNA, (2) determine the  chemical base pair sequences of human  DNA, (3) store this information in databases,  (4) improve data analysis tools, (5) conduct technology transfer, and (6) address the ethical, legal, and social issues that may arise from the project. The full sequence of the human genome was completed and published in April 2003. Through its policy of open data release, the  Human Genome Project facilitated the  research of others. The Human Genome  Project also anticipated and promoted  commercializing genomic resources and  applications by establishing an infrastructure  and supporting private-sector technology  development. Consequently, the project led  to new tools to support biological research.  Further, the data and technologies generated  by the project and related research present a  broad array of commercial opportunities  across many areas of the economy. These  include more individualized diagnostics,  prognostics, drugs, and other therapies as  well as hardier, more nutritious, and healthier  crops and animals, among other applications.

At the same time, experts said that while information sharing is important,  there are risks, such as foreign commercialization of U.S. intellectual  property. Experts noted that the world is increasingly competing with the  United States in research for transformational technological advances.  One expert cautioned that while information sharing is important for  transformational technologies, it must be done carefully so that other  companies do not exploit a technology or it is not leaked to a foreign  competitor. Similarly, one stakeholder said that while information sharing  is beneficial at the early stages of technology development, a balanced  approach to information sharing—an approach that allows for trade  secrets and that guards some research results—is needed once a  technology is no longer in the early stages of development.

In light of these tradeoffs, experts emphasized the importance of ensuring  that intellectual property protections support U.S. competitiveness;  however, they also described challenges with how intellectual property is  managed in the United States. For example, experts said it can be  challenging to bring industry and academic researchers into partnerships  that support transformational technological advances. Experts explained  that some collaborators are willing to openly share their intellectual  property, while other experts noted that some collaborators may be less  inclined to do so because they view intellectual property as a profitable  commodity. Additionally, one expert cited differences between potential  industry and academic collaborators’ knowledge of, and attention paid to,  developing technologies into commercial products as a potential barrier.  One expert said that foreign countries generally allow university- developed intellectual property to be owned and licensed by the inventors  or third-party companies (instead of the university). This can create a  foundation for a startup company or make it easier to get the interest of  companies who would like to acquire a university-based technology or  process. The expert noted that in one circumstance, this has given an  advantage to a foreign university in recruiting top researchers, helping it  to become a leader in quantum computing. However, another expert  stated that most major research universities have moved to a model of  developing partnerships with firms, especially startups, which has minimal  upfront licensing costs, and shared gains over time if the project is  successful—according to that expert, such universities typically share  research intellectual property rights with faculty inventors.

Focusing on Technology Development and Commercialization

Focusing on technology development and commercialization is another  policy consideration that experts identified for maintaining U.S.  competitiveness through transformational technological advances.  According to experts, the United States’ “innovation ecosystem”—the  network of public and private institutions within a country whose activities  and interactions initiate, develop, commercialize, and diffuse new  technology innovations—has either lost or needs better mechanisms for  commercializing technologies to maintain U.S. competitiveness. To  address this issue, experts discussed how the federal government could  focus on technology development and commercialization by providing  support across multiple stages of innovation and support for the  development of tools to enhance innovation.

Providing Longer-Term Assistance to Support Technology Development

Experts discussed a need to improve technology development and  commercialization by providing support across multiple stages of  innovation. Experts described how sustained federal research  investments have led to key scientific discoveries, including, for example,  NIST and IARPA’s decade-long support for quantum computing research  and NSF’s investment in synthetic biology. However, while experts said  federal agencies’ ability to support new discoveries is a strength, they  explained that the United States is losing the ability to commercialize  technologies that are invented here. For example, according to one  expert, while the technology might soon be available to build small (100  qubit) quantum computers, the United States does not have the  necessary enterprise in place to manufacture those systems. Experts  stated that it may take decades or more from the time research is funded  until it is commercialized. During this intervening period, significant  investment is needed to support the innovation cycle in terms of research  in the design, building, and testing of new product prototypes and  production processes.

Experts described an increasing reliance, over time, on venture capital  funding to support investments in the innovation cycle. They said that  while this is generally working well in some areas such as software and  biotechnology, venture capital investors have become less willing to  support other technologies that require higher levels of capital investment,  longer-term returns, and greater risk. For example, one expert stated that  while the U.S. venture capital system spends $70 billion annually on  technology commercialization activities, in 2015, the expert estimated that  5 percent of venture capital funding went to hard technologies. Multiple  reports in recent years have documented the challenges associated with  how the innovation cycle is supported in the United States and its  implications for the domestic commercialization and production of new  technologies. For example, in a 2012 report, the National Research  Council stated that discoveries and inventions originating from research  conducted at U.S. universities, corporations, and national laboratories no  longer naturally led to products that are commercialized and  manufactured within the United States. According to this report,  manufacturing is important in developing new products because in many  high-technology industries, design cannot easily be separated from  manufacturing, and a lack of sustained investment in research and  infrastructure threatens to damage the U.S. innovation ecosystem,  economy, and security.

To address this issue, experts discussed a need to provide longer-term  federal financial assistance to better support technology development  across multiple stages of innovation. Experts stated that federal agencies  often support research on short-term funding cycles (e.g., 3 years or less)  that may not be conducive to the long-term support sometimes needed to  effectively de-risk potentially transformational technologies. A 2017  National Academies report cited short-term funding as one factor that has  resulted in U.S. science losing its flexibility and nimbleness, elements that  feed new discovery. Additionally, experts said that federal agencies’  support may not extend to the later stages of technology development but  providing longer-term support for research is an important part of the  federal government’s role in advancing transformational technologies. For  example, one expert said that long-term federal support facilitates  creating a research infrastructure that can support a technology’s  development.

Experts cited several examples of how federal agencies’ programs  provide different models for supporting technology development across  multiple stages of innovation.

Advanced Technology Program. Experts cited NIST’s Advanced Technology Program—which COMPETES 2007 repealed—as a success in terms of its efforts to support transformational research.Experts cited several aspects of the program in discussing its success, including its support for (1) research that accelerated the development of high-risk technologies with the potential for broad- based economic benefits to the nation; (2) information sharing across different sectors; (3) active project management and workshops that  taught awardees how to pitch their technology to venture capital  investors, according to one expert. One expert noted that the  program collaborated with NIH to develop diagnostic approaches that  advanced the genomic revolution.

ARPA-E. Experts described ARPA-E—which was modeled after DARPA—as an important challenge-based federal effort to advance technologies in areas aligned with DOE’s mission. Aspects of the ARPA-E model one expert cited as important to the program’s ability to support transformational technological advances included, among others, support for higher-risk research and the autonomy that program directors have in seeking expert input and selecting research projects.

Manufacturing USA Institutes. One expert described the Manufacturing USA institutes as an important federal effort to support emerging technologies across multiple stages of innovation. Another expert explained that in order to continue to capture the economic benefits of the innovation system, the United States needs to embed the knowledge for technology production locally within the country. The first expert said the Manufacturing USA institutes help increase the connectivity among different actors involved with specific technology areas and improve their ability to leverage advances in  those areas.

Experts also discussed how other countries’ long-term funding for  research efforts may help them support technology development. For  example, one expert discussed Germany’s Fraunhofer Institutes, where  the government makes research investments over time frames of 5 or  even 20 years and rewards successful projects with funding increases  each year. In addition, one expert noted that other countries such as  the Netherlands and Singapore also provide long-term research funding,  allowing them to develop the broader research infrastructure necessary to  support technology development. In the area of quantum computing, one  expert stated that the Netherlands’ investment has contributed to one of  the largest quantum computing-focused efforts in the world. According to  one expert, if U.S. researchers do not conduct the research necessary  over the long term to prove their research ideas, other countries will have  the opportunity to pick up where U.S. researchers leave off and  commercialize technologies based on this research.

Supporting Development of Tools to Enhance Innovation

Experts stated that tool development is critical to transformational  technological advances and discussed a need for federal government  support for tool development to maintain U.S. competitiveness. A tool is  something—such as equipment used for a specific purpose, a modified  biological system, or a computer program—that is used to perform a task  or that is needed to practice a profession. According to one expert, tools  are crucial supporting technologies that are necessary for the product  development process. According to recent reports, research in tools  development can lead to the introduction of new products, materials, or  the ability to produce materials at the commercial level.

A bioprinted coronary artery.  3D bioprinting is a tool that scientists are  developing in the field of regenerative  medicine. 3D bioprinting uses 3D printing with  biological materials to create skin, bones,  arteries, and a variety of other tissues and  organs. For example, the Department of  Defense has conducted research into using  3D bioprinting to repair skin damaged by  burns—injuries that account for 10 to 30  percent of battlefield casualties. To repair  burned skin, researchers have created scans  of burns that a computer then uses to have a  3D printer reconstruct the burned skin.  3D bioprinting has also been used to create  small blood vessel networks that contain living  cells that have joined with the blood vessel  networks in a mouse, allowing blood to  circulate through them. Such printed blood  vessels could be used to replace a damaged  heart muscle. In the future, such organs could  be grown using 3D bioprinting and the cells of  the person who needs the organ, and they  could be used in place of transplanted organs.  3D bioprinted tissues could also be used to  test the safety of new drugs. 3D bioprinting is  in the early stages of development.

Experts explained that the United States is at risk of losing its ability to  develop tools, and they identified challenges to tool development,  including the following:

Unclear needs and long time frames. According to experts, industry may be less likely to invest in tool development when tools do not support existing products, but, rather, are a part of solving technology challenges that are not clearly defined. In this context, experts explained that tool development can take a relatively long time, which may not be compatible with industry’s short innovation time frames.

Potentially high or unrecoverable costs. Developing tools is expensive, according to experts, and when creating a new tool, companies have to consider whether they will be able to recover their costs. One expert described a circumstance in which a modified laser was needed to support research on a quantum system. The expert explained that a laser manufacturing company would need to change its production line in order to make the modified laser, and it would be very expensive for the company to adjust its production line to make only the modified laser.

Experts emphasized the important role federal agencies can play in  helping overcome these challenges to tool development. For example,  experts described the importance of federal support for developing  measurement tools to accelerate and improve the learning cycles around  designing, building, and testing technologies and products. Experts  specifically cited NIST’s role in the development of measurement tools.  For example, through the NIST-on-a-Chip program NIST is developing  ultra-compact, inexpensive tools that will measure quantities such as  time, distance, current and voltage, and temperature and pressure and  that will allow measurement technologies to be deployed without requiring  traditional measurement services. In line with NIST’s goals, the private  sector will manufacture and distribute these technologies. Experts also  noted the important role federal agencies play in providing access to  tools, such as technology testbed facilities to support de-risking  technologies through prototyping and other development activities.

Strengthening the Science and Technology Workforce

Experts identified strengthening the science and technology workforce as  a consideration for maintaining U.S. competitiveness through  transformational technological advances. According to experts, there is a  need for federal agencies to work with academia and industry to improve  connections between the training academia provides and what industry  needs, such as interdisciplinary training. Experts further discussed the  recruitment of researchers and the retention of research talent and a  technically trained workforce; according to experts, attracting researchers  has historically been a U.S. strength, but this ability may be at risk.

Improving Connections between Academic Training and Industry Needs

Experts identified the need to improve connections between academic  institutions and industry so that the training academia provides  corresponds to industry’s needs, particularly for interdisciplinary research  fields. Without strengthening these connections, according to experts,  academia may not deliver the interdisciplinary training needed for some  research areas. Experts identified the systems engineering training  needed to build a quantum computer as one such area of interdisciplinary  training. For example, one expert said engineers are usually unfamiliar  with the quantum mechanics used in a quantum computer and this is  challenging since knowledge of both disciplines—quantum mechanics  and engineering—is necessary to develop the technology. Also, not many  quantum computing researchers are trained in the fields of computer  science or engineering, according to stakeholders and agency officials we  interviewed. A few experts said that because universities are not training  the researchers needed in some interdisciplinary areas, there are not  enough researchers in those areas available for industry to hire.

Experts, other stakeholders and agency officials we interviewed, as well  as some recent reports, identified several factors that may contribute to a  disconnect between academic training and industry needs. For example,  experts explained that universities appear to operate on the assumption  that industry, not universities, must teach students the practical skills  needed to be productive members of an engineering team.  Additionally, according to a 2012 report by the National Research  Council, job markets and careers for doctoral scientists and engineers  have shifted since 1990 so that more than 50 percent of new doctorates  work outside of academia, but there are few incentives to motivate  graduate programs to align doctoral education with evolving employment  activities. According to one expert, graduate education is largely  supported by federally funded research awards to universities which tend  to support basic research, not applied research or development. This  expert further stated that as a result, graduate students are not taught  later stage applied work relevant to industry because that has not been  what federal research has historically funded. According to a different  2012 National Research Council report, cultural barriers often separate  industry from academia and are reinforced by organizational incentives— universities have traditionally emphasized the need to publish research,  not commercialize it. Further, one expert, a stakeholder, and an agency  official we interviewed said that universities generally were not hiring  faculty who focus on quantum computing as part of their computer  science and engineering departments. The expert attributed this to limited  funding available to support those research programs. According to this  expert, the financial assistance federal research programs provide can  send an important signal to universities that can lead to evolving  academic programs and hiring in interdisciplinary fields. A 2016 MIT  report made similar observations and said that many universities remain  siloed along departmental lines and need resources and structures that  allow for team teaching—two people from different research areas co- teaching a course—or research in which students from different  disciplines could be paired to answer a research question. However, in  synthetic biology, one expert noted that some universities have started  entirely new Departments of Bioengineering because aspects of synthetic  biology contribute to the development of an independent, distinctive, and  complementary type of engineering. This has resulted in the development  of a new curriculum that incorporates synthetic biology into the training  and development of bioengineers, according to this expert.

Experts discussed the importance of recruiting researchers and retaining  talent and a technically trained workforce. Experts stated that attracting  researchers to come and stay in the United States has historically been a  national strength. The Congressional Budget Office has reported that  foreign-born workers contribute disproportionately to innovation.  Further, according to this report, foreign-born researchers account for a  disproportionate number of the scientific researchers who yield many of  the big discoveries and conceptual breakthroughs that drive science.

However, according to a few experts, and a National Research Council  report, the United States is increasingly competing with other countries to  recruit and retain talented researchers. Countries such as Canada,  China, and Singapore are attracting talented researchers to their  universities and research institutes by offering high salaries and the  opportunity to run well-funded programs, according to a National  Research Council report. For example, according to a few experts,  China started the Thousand Talents Program in 2008 to get talented  researchers to return to China. The Thousand Talents Program’s goal  is to bring top talent trained overseas to China on a full- or part-time  basis. One expert gave the example of a university president resigning  from a U.S. university because he believed the possibilities for research  were greater in Asia. According to one expert, the nation’s ability to recruit  and retain researchers may be at risk because the United States is not  working to retain and incentivize talent. According to that expert, this puts  the nation at risk of missing out on the next global transformational  technological advance.

According to some experts, one challenge to retaining talent in the United  States is that limited job opportunities are available to young researchers  trained in certain areas. It is important to create conditions for young  researchers to find employment in research and development, according  to one expert, so that they can contribute to these areas. Creating the  right incentive structure for people to produce transformational  technologies in the United States is important, according to another  expert, because when technologies are produced in the United States,  the skills needed to produce them become embedded in that community.  We have previously reported that too much location of skilled  manufacturing jobs abroad can, in general, put the United States at a  disadvantage in terms of its ability to design new products, according to  participants in a 2013 forum on nanomanufacturing. Similarly, in a 2012  report, the National Research Council stated that manufacturing is  integral to new product development, and production lines are linked to  an iterative innovation chain that includes research and development,  product refinement, and full-scale production. In many high-technology  industries, design cannot be easily separated from manufacturing, and  talent availability is the most important factor for deciding where to place  a production facility. In some cases, according to this 2012 report,  companies are choosing to produce abroad because of concerns related  to the capacity of the U. S. supply chain, technical skills of U.S. workers,  and the investment climate for high-volume manufacturing. Also  according to this report, as a result of these factors, the United States is  finding it increasingly difficult to capture the economic value generated by  public and private investments in research and development.

Federal support for research in areas such as quantum computing and  synthetic biology can help promote U.S. competitiveness in the global  economy. For example, advances in quantum computing have the  potential to lead to transformational advances in national security  technologies or technology areas that rely heavily on simulation, such as  pharmaceuticals and materials science for advanced manufacturing.  Research in synthetic biology could help achieve significant advances in  health care, energy, and other sectors. When agencies collaborate on  their research efforts, they can produce more public value than when they  act alone. Moreover, collaboration through mechanisms such as  interagency groups can help address complex issues, such as those  remaining to be resolved in quantum computing and synthetic biology.  Collaboration can also mitigate challenges associated with fragmentation  of efforts across multiple agencies, as well as potential overlap and  duplication.

NSTC and federal agencies have taken steps, building on earlier efforts,  to coordinate their activities in the areas of quantum computing and  synthetic biology. Specifically, both the new QIS Subcommittee and the  new synthetic biology working group have taken initial steps to implement  certain leading practices that can enhance and sustain collaborative  efforts. For example, both have taken steps toward agreeing on roles and  responsibilities. These steps could help address problems identified in  previous interagency coordination efforts. However, both the  subcommittee and working group are recently established and have had  limited time to fully implement the leading practices that we describe in  this report. As the subcommittee and working group move forward, by  taking steps to fully implement these leading practices for collaboration,  member agencies could better marshal their collective efforts to support  research in quantum computing and synthetic biology and help maintain  U.S. competitiveness through transformational technological advances.

We are making a total of five recommendations, including one to OSTP,  one to Commerce, one to DOE, and two to NSF.

As the QIS Subcommittee moves forward, the Office of Science and Technology Policy co-chair, in coordination with other co-chairs and participating agency officials, should take steps to fully implement leading practices that enhance and sustain collaboration. (Recommendation 1)

As the QIS Subcommittee moves forward, the Department of Commerce co-chair, in coordination with other co-chairs and participating agency officials, should take steps to fully implement leading practices that enhance and sustain collaboration. (Recommendation 2)

As the QIS Subcommittee moves forward, the Department of Energy co-chair, in coordination with other co-chairs and participating agency officials, should take steps to fully implement leading practices that enhance and sustain collaboration. (Recommendation 3)

As the QIS Subcommittee moves forward, the National Science Foundation co-chair, in coordination with other co-chairs and participating agency officials, should take steps to fully implement leading practices that enhance and sustain collaboration. (Recommendation 4)

As the Interagency Working Group on Synthetic Biology moves forward, the Director of the National Science Foundation, in coordination with participating agency officials, should take steps to fully implement leading practices that enhance and sustain collaboration. (Recommendation 5)

Agency Comments, Third-Party Views, and Our Evaluation

We provided a draft of this product to Commerce, DOD, EPA, DOE, DHS,  HHS, NASA, NSF, ODNI, OSTP and USDA for comment. Commerce,  DOE, NSF, and OSTP generally agreed with the recommendations  directed to them.

Commerce, DOE, and NSF provided written comments that are  reproduced in appendixes IV, V, and VI, respectively. In expressing  concurrence with the recommendations directed to them, these agencies’  written comments discussed aspects of the interagency groups’ efforts we  examined in our report or the agencies’ own efforts related to coordination  and collaboration.

OSTP’s General Counsel provided OSTP’s comments by email. In its  comments, OSTP stated that it sees value in our recommendation and  will implement the recommendation as resources allow. However, OSTP  expressed concern about the impact that resource limitations could have  on its ability to implement the recommendation. We recognize that OSTP  faces certain resource limitations. However, we believe that implementing  our recommendation would allow leveraging of limited resources across  the agencies participating in a collaborative effort.

In an email from an official with the Office of the Chief Financial Officer in  USDA’s Agricultural Research Service, USDA provided general  comments on our findings and our recommendation pertaining to the  Interagency Working Group on Synthetic Biology. Specifically, USDA  concurred that federal support for research and development help drive  technological advances and promote U.S. competitiveness. USDA also  agreed that the leading practices we discuss in our report can enhance  and sustain interagency collaboration, and it expressed support for the  implementation of these practices in the Interagency Working Group on  Synthetic Biology, consistent with our recommendation.

In addition, Commerce, DHS, DOE, EPA, HHS, NASA, and OSTP  provided technical comments, which we incorporated as appropriate.  Officials from DOD and ODNI stated via email that they had no comments  on the report.

We also provided a draft of this report to a participant who served as  moderator in our October 2017 expert meeting on research for  transformational technological advances. We requested his views on  aspects of the report on which he has expertise and, in particular, the  characterization of statements made by experts at our meeting. He  provided technical comments, which we incorporated as appropriate.

We are sending copies of this report to the appropriate congressional  committees; the Secretaries of Agriculture, Commerce, Defense, Energy,  Health and Human Services, and Homeland Security; the Administrators  of the Environmental Protection Agency and the National Aeronautics and  Space Administration; the Directors of National Intelligence, the National  Science Foundation and the Office of Science and Technology Policy;  and other interested parties. In addition, this report is available at no  charge on the GAO website at http://www.gao.gov.

If you or your staff members have any questions about this report, please  contact me at (202) 512-3841 or neumannj@gao.gov. Contact points for  our Offices of Congressional Relations and Public Affairs may be found  on the last page of this report. Key contributors to this report are listed in  appendix VII.

Appendix I: Objectives, Scope, and Methodology

The objectives of our review were to (1) describe federal agencies’ and  nonfederal entities’ support for research for transformational technological  advances in selected areas, (2) examine federal agencies’ coordination  on this research, and (3) provide experts’ views on considerations for  maintaining U.S. competitiveness through transformational technological  advances.

For the purposes of this report, we selected quantum computing (a sub- area of quantum information science) and synthetic biology (the  intersection of biology and engineering that focuses on the modification or  creation of novel biological systems) as examples of research for  transformational technological advances. We selected these two areas of  research because they: (1) represent enabling or platform technologies,  which could lead to other advances, (2) are supported by a mix of federal  agencies and nonfederal entities, and (3) represent areas of  congressional interest in which we have not recently conducted work.

We conducted this performance audit from November 2016 to September  2018 in accordance with generally accepted government auditing  standards. Those standards require that we plan and perform the audit to  obtain sufficient, appropriate evidence to provide a reasonable basis for  our findings and conclusions based on our audit objectives. We believe  that the evidence obtained provides a reasonable basis for our findings  and conclusions based on our audit objectives.

To describe federal agencies’ and nonfederal entities’ support for  research for transformational technological advances in quantum  computing or synthetic biology we reviewed agency documentation,  relevant literature, and our prior work related to federal research efforts.  We focused on federal and nonfederal efforts in fiscal years 2016 through  the second quarter of fiscal year 2018. For example, we reviewed the  National Science and Technology Council’s 2016 report on advancing  quantum information science which discusses the state of the research  area and federal involvement. We also interviewed officials from 10  agencies and departments that have ongoing work in either quantum  computing or synthetic biology, or in some instances, work in both  research areas. These agencies were the: Department of Commerce,  Department of Defense, Environmental Protection Agency, Department of  Energy, Department of Homeland Security, Department of Health and  Human Services, National Aeronautics and Space Administration,  National Science Foundation (NSF), Office of the Director of National  Intelligence, and U.S. Department of Agriculture. We initially selected  federal agencies on the basis of those that had total research and  development obligations of $500 million or greater in fiscal year 2016  according to NSF’s Survey of Federal Funds for Research and  Development. Additionally, we included an agency which we learned,  through the course of our work, had significant ongoing work in both  research areas. We did not seek to develop comprehensive information  on federal agencies’ efforts to support research in quantum computing  and synthetic biology. As a result, federal agencies could have ongoing  efforts in these two areas that we do not discuss in our report.

To examine the funding federal agencies provide for quantum computing  and synthetic biology research, we requested data on obligations for  quantum computing and synthetic biology research for fiscal years 2016  through 2017, information on the type of research funded, and the names  of individual studies or projects. We requested funding data from all  agencies within our scope but some agencies did not provide such data.  We assessed the reliability of the data we obtained by checking for  obvious errors in accuracy and completeness and by comparing the data  with other sources of funding information, such as agency budget  documents, where possible. We determined that the data were sufficiently  reliable for reporting an approximate, minimum amount of federal financial  assistance obligated for quantum computing and synthetic biology  research.

To examine the extent to which nonfederal entities have supported  research related to synthetic biology and quantum computing, we  interviewed stakeholders from 21 nonfederal entities with experience in  the areas of quantum computing, synthetic biology, or federal research  more broadly. To collect a range of viewpoints, we selected nonfederal  entities from industry, academia, nonprofit organizations, and professional  associations. The 21 nonfederal entities we interviewed included:  1. American Chemical Society 2. American Physical Society 3. Arizona State University 4. Georgia Institute of Technology 8.

Institute of Electrical and Electronics Engineers 10. Information Technology and Innovation Foundation 12. Massachusetts Institute of Technology (MIT)13. Materials Research Society 15. National Venture Capital Association 17. Science and Technology Policy Institute 18. University of California 19. University of Colorado We also defined the people cited in this report in the following manner:  1. Experts: individuals who participated in our expert meeting. 2. Stakeholders: academic researchers, industry officials, and representatives of professional organizations who we interviewed. This group does not include agency officials. 3. Agency officials: federal officials we interviewed.

We identified and selected these stakeholders through a literature review  and referrals. We conducted a literature review to learn about the current  state of each research area as well as to identify relevant stakeholders in  the areas of synthetic biology and quantum computing. We then  contacted the stakeholders for interviews and asked them for additional  references. We interviewed stakeholders both in person and over the  phone.

We did not seek to develop comprehensive information on nonfederal  efforts to support research in quantum computing and synthetic biology.  As a result, we acknowledge that there are nonfederal entities that may  have ongoing efforts in these two areas that we do not discuss in our  report.

Federal Agencies’ Coordination on Research

To examine federal agencies’ coordination on quantum computing and  synthetic biology research, we identified coordination efforts in fiscal year  2016 through the second quarter of fiscal year 2018 through our review of  agency documentation and interviews with federal officials. Additionally,  we interviewed officials with the Office of Science and Technology Policy.  For ongoing interagency coordination efforts, we compared agencies’  efforts with selected leading practices for enhancing and sustaining  collaboration. We selected six of the eight practices based on their  relevance to the operations of the interagency coordination efforts we  identified. In this report, and in our past work, we define collaboration  broadly as any joint activity that is intended to produce more public value  than could be produced when organizations act alone. Through  interviews and a data request, we asked agency officials to provide  information on their efforts to coordinate quantum computing and  synthetic biology research from fiscal year 2016 through the second  quarter of fiscal year 2018. For interagency groups related to quantum  computing and synthetic biology, we obtained information through June  2018.

To provide experts’ views on considerations for maintaining U.S.  competitiveness through transformational technological advances, we  convened a meeting of 19 experts on October 12 and 13, 2017, with the  assistance of the National Academies of Sciences, Engineering, and  Medicine. The experts included current and former federal officials, as  well as subject matter experts from industry, academia, nonprofit  organizations, and professional associations. About half of the experts  were subject matter experts in the areas of quantum computing or  synthetic biology, while the other half were experts with broader  perspectives on the role of federal and nonfederal entities in supporting  research for transformational technological advances. We worked with  the National Academies staff to select experts with a range of viewpoints.

Prior to the meeting, we worked with National Academies staff to help  ensure balance and to assess potential conflicts of interest among the  experts. For example, we asked all participating experts to provide  information on (1) whether their immediate family had any investments or  assets that could be affected, in a direct and predictable way, by a  decision or action based on the information or opinions they would  provide to GAO; (2) whether they or their spouse received any income or  hold any organizational positions that could be affected, in a direct and  predictable way, by the information or opinions they would provide GAO;  and (3) whether there were any other circumstances, not addressed in  the two previous questions, that could be reasonably viewed by others as  affecting participants’ point of view on the topics to be discussed. We  received signed responses from all participating experts. Three of the 19  experts reported potential conflicts. We evaluated their statements and  determined that they did not have any inappropriate biases when taken in  the context of the overall group of experts taking part in the meeting. As a  result of these efforts, we determined that the group of 19 experts,  overall, was balanced and had no inappropriate biases. However, the  views of these experts cannot be generalized to everyone with expertise  on research for transformational technological advances; they represent  only the views of the experts who participated in our meeting. We list the  experts who participated in our meeting in Appendix II.

We divided the 2-day expert meeting into 8 sessions focused on a range  of topics, such as the role of federal and nonfederal entities in keeping the  United States competitive. Each session featured an opening  presentation by two selected experts, followed by open discussion among  all meeting participants. At the end of each session, one expert was  tasked with highlighting the key themes discussed during that session.  We then solicited feedback from the experts to determine whether there  were any additional comments they wanted to add to those themes. We  recorded and transcribed the meeting to ensure that we accurately  captured the experts’ statements.

We analyzed the information gathered from the experts by reviewing and  conducting a content analysis of the transcript and identifying  considerations for maintaining U.S. competitiveness based on  categorizing the experts’ comments. For purposes of quantifying expert  remarks, we refer to a statement from an individual expert as being from  one expert, and unless there is significant disagreement in the transcript,  we refer to statements from two or more experts as being from experts. In  cases of significant disagreement in the transcript, we refer to statements  from two to three experts as being from a few experts, and statements  from four to six experts as being from some experts. Before publication  and consistent with our quality assurance framework, we provided the  experts with a draft of our report and asked them to provide their views on  whether our overall characterization of the meeting generally reflected the  considerations discussed during the meeting. Of the 18 experts who  responded to our request for review, 13 experts agreed that our overall  characterization generally reflected the key considerations identified  during the meeting, one partially agreed, and one differed with our  report’s presentation of specific issues regarding synthetic biology. We  incorporated feedback experts provided on the draft, as appropriate.

To corroborate statements made by the experts on particular topics, as  appropriate, we identified and analyzed studies and reports by agencies,  the National Academies, and others that were recommended to us by  experts. In addition, we compared the experts’ statements to other  information provided by agency officials and stakeholders we interviewed.

Appendix II: Participants in GAO’s Meeting on Research for Transformational Technological Advances

Appendix II: Participants in GAO’s Meeting on  Research for Transformational Technological  Advances Affiliation  Ceres Nanosciences, Inc.

Appendix III: Funding/Investment Gap in the Manufacturing-Innovation Process (Corresponds to fig. 1)

Appendix III: Funding/Investment Gap in the  Manufacturing-Innovation Process  (Corresponds to fig. 1)

Figure 3 shows the potential gap during the middle stages of innovation,  in which innovators may have difficulty finding financial support. The  figure includes a static display of the rollover information included in figure  1, which is interactive.

Figure 3 Funding/Investment Gap in the Manufacturing-Innovation Process (Corresponds to fig. 1)

Appendix V: Comments from the Department of Energy

Appendix VI: Comments from the National Science Foundation

Appendix VII: GAO Contact and Staff Acknowledgments

In addition to the contact named above, the following individuals made  contributions to this report: Christopher Murray (Assistant Director),  Angela Miles (Analyst-in-Charge), Justin Fisher, Scott Fletcher, Ashley  Grant, Charlotte E. Hinkle, Gwen Kirby, Patricia Moye, Cynthia Norris,  Emily Pinto, Tind Shepper Ryen, McKenna Storey, and Walter Vance.

Many federal agencies support research on quantum computing and synthetic biology. Experts we convened identified considerations, such as taking a strategic approach, that could help maintain U.S. competitiveness in these and other fields.

We found that agencies have taken steps to collaborate on these activities, such as creating new interagency groups, but have not fully implemented key collaboration practices—e.g., agreeing on roles and responsibilities. We recommended they implement these practices.